0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-21I7150
Home | Market Reports | Health| Medical Devices & Equipment
Global Neuromodulation Devices and Implantable Infusion Pumps Market Insights and Forecast to 2028
BUY CHAPTERS

Global Neuromodulation Devices and Implantable Infusion Pumps Market Research Report 2026

Code: QYRE-Auto-21I7150
Report
2026-02-03
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Neuromodulation Devices and Implantable Infusion Pumps Market

The global Neuromodulation Devices and Implantable Infusion Pumps market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Neuromodulation Devices and Implantable Infusion Pumps competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
An implantable infusion pump (IIP) is intended to provide long-term continuous or intermittent drug infusion. Possible routes of administration include intravenous, intra-arterial, subcutaneous, intraperitoneal, intrathecal, epidural, and intraventricular. The IIP is surgically placed in a subcutaneous pocket under the infraclavicular fossa or in the abdominal wall, and a catheter is threaded into the desired position.
In United States, Neuromodulation Devices and Implantable Infusion Pumps key players include Medtronic, Boston Scientific Corporation, St. Jude Medical, etc. Global top three manufacturers hold a share over 75%.
Midwest is the largest market, with a share about 50%, followed by South, and West, both have a share over 45 percent.
In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%. And in terms of application, the largest application is Pain, followed by Parkinson"s disease, Epilepsy, etc.
This report delivers a comprehensive overview of the global Neuromodulation Devices and Implantable Infusion Pumps market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Neuromodulation Devices and Implantable Infusion Pumps. The Neuromodulation Devices and Implantable Infusion Pumps market size, estimates, and forecasts are provided in terms of sales volume (Unit) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Neuromodulation Devices and Implantable Infusion Pumps market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Neuromodulation Devices and Implantable Infusion Pumps manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Neuromodulation Devices and Implantable Infusion Pumps Market Report

Report Metric Details
Report Name Neuromodulation Devices and Implantable Infusion Pumps Market
Segment by Type
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Sacral Nerve Stimulation
  • Vagal Nerve Stimulation
  • Gastric Stimulation
  • Transcranial Magnetic Stimulation
  • Transcutaneous Electrical Stimulation
  • Other
by Application
  • Parkinson's Disease
  • Epilepsy
  • Pain
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Neuromodulation Devices and Implantable Infusion Pumps manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Neuromodulation Devices and Implantable Infusion Pumps sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

What is the market share of major companies in Neuromodulation Devices and Implantable Infusion Pumps Market?

Ans: Global top three manufacturers hold a share over 75%.

What is the Neuromodulation Devices and Implantable Infusion Pumps Market share by type?

Ans: In terms of product, Spinal Cord Stimulation is the largest segment, with a share over 50%.

Who are the main players in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The main players in the Neuromodulation Devices and Implantable Infusion Pumps Market are Medtronic, Boston Scientific Corporation, St. Jude Medical, Synapse Biomedical, Nevro Corporation, Neuropace, Cyberonics, Autonomic Technologies, Avery Biomedical, Greatbatch Medical

What are the Application segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The Applications covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report are Parkinson's Disease, Epilepsy, Pain, Other

What are the Type segmentation covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report?

Ans: The Types covered in the Neuromodulation Devices and Implantable Infusion Pumps Market report are Spinal Cord Stimulation, Deep Brain Stimulation, Sacral Nerve Stimulation, Vagal Nerve Stimulation, Gastric Stimulation, Transcranial Magnetic Stimulation, Transcutaneous Electrical Stimulation, Other

1 Neuromodulation Devices and Implantable Infusion Pumps Market Overview
1.1 Product Definition
1.2 Neuromodulation Devices and Implantable Infusion Pumps by Type
1.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Type: 2025 vs 2032
1.2.2 Spinal Cord Stimulation
1.2.3 Deep Brain Stimulation
1.2.4 Sacral Nerve Stimulation
1.2.5 Vagal Nerve Stimulation
1.2.6 Gastric Stimulation
1.2.7 Transcranial Magnetic Stimulation
1.2.8 Transcutaneous Electrical Stimulation
1.2.9 Other
1.3 Neuromodulation Devices and Implantable Infusion Pumps by Application
1.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Application: 2025 vs 2032
1.3.2 Parkinson's Disease
1.3.3 Epilepsy
1.3.4 Pain
1.3.5 Other
1.4 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size Estimates and Forecasts
1.4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue 2021–2032
1.4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales 2021–2032
1.4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Neuromodulation Devices and Implantable Infusion Pumps Market Competition by Manufacturers
2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2021–2026)
2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Neuromodulation Devices and Implantable Infusion Pumps, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Types and Applications
2.7 Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Date of Entry into the Industry
2.8 Global Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation and Trends
2.8.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Neuromodulation Devices and Implantable Infusion Pumps Players Market Share by Revenue
2.8.3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Neuromodulation Devices and Implantable Infusion Pumps Market Scenario by Region
3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021–2032
3.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2021–2026
3.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region: 2027–2032
3.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021–2032
3.3.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021–2026
3.3.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2027–2032
3.4 North America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.4.1 North America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021–2032)
3.4.3 North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.5.1 Europe Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021–2032)
3.5.3 Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Region
3.6.1 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (2021–2032)
3.6.3 Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.7.1 Latin America Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021–2032)
3.7.3 Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Facts & Figures by Country
3.8.1 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (2021–2032)
3.8.3 Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021–2032)
4.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2021–2026)
4.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Type (2027–2032)
4.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021–2032)
4.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021–2032)
4.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2021–2026)
4.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Type (2027–2032)
4.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021–2032)
4.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Type (2021–2032)
5 Segment by Application
5.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021–2032)
5.1.1 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2021–2026)
5.1.2 Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Application (2027–2032)
5.1.3 Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021–2032)
5.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021–2032)
5.2.1 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2021–2026)
5.2.2 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Application (2027–2032)
5.2.3 Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021–2032)
5.3 Global Neuromodulation Devices and Implantable Infusion Pumps Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Medtronic
6.1.1 Medtronic Company Information
6.1.2 Medtronic Description and Business Overview
6.1.3 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.1.5 Medtronic Recent Developments/Updates
6.2 Boston Scientific Corporation
6.2.1 Boston Scientific Corporation Company Information
6.2.2 Boston Scientific Corporation Description and Business Overview
6.2.3 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.2.5 Boston Scientific Corporation Recent Developments/Updates
6.3 St. Jude Medical
6.3.1 St. Jude Medical Company Information
6.3.2 St. Jude Medical Description and Business Overview
6.3.3 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.3.5 St. Jude Medical Recent Developments/Updates
6.4 Synapse Biomedical
6.4.1 Synapse Biomedical Company Information
6.4.2 Synapse Biomedical Description and Business Overview
6.4.3 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.4.5 Synapse Biomedical Recent Developments/Updates
6.5 Nevro Corporation
6.5.1 Nevro Corporation Company Information
6.5.2 Nevro Corporation Description and Business Overview
6.5.3 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.5.5 Nevro Corporation Recent Developments/Updates
6.6 Neuropace
6.6.1 Neuropace Company Information
6.6.2 Neuropace Description and Business Overview
6.6.3 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.6.5 Neuropace Recent Developments/Updates
6.7 Cyberonics
6.7.1 Cyberonics Company Information
6.7.2 Cyberonics Description and Business Overview
6.7.3 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.7.5 Cyberonics Recent Developments/Updates
6.8 Autonomic Technologies
6.8.1 Autonomic Technologies Company Information
6.8.2 Autonomic Technologies Description and Business Overview
6.8.3 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.8.5 Autonomic Technologies Recent Developments/Updates
6.9 Avery Biomedical
6.9.1 Avery Biomedical Company Information
6.9.2 Avery Biomedical Description and Business Overview
6.9.3 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.9.5 Avery Biomedical Recent Developments/Updates
6.10 Greatbatch Medical
6.10.1 Greatbatch Medical Company Information
6.10.2 Greatbatch Medical Description and Business Overview
6.10.3 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product Portfolio
6.10.5 Greatbatch Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Chain Analysis
7.2 Neuromodulation Devices and Implantable Infusion Pumps Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neuromodulation Devices and Implantable Infusion Pumps Production Mode & Process Analysis
7.4 Neuromodulation Devices and Implantable Infusion Pumps Sales and Marketing
7.4.1 Neuromodulation Devices and Implantable Infusion Pumps Sales Channels
7.4.2 Neuromodulation Devices and Implantable Infusion Pumps Distributors
7.5 Neuromodulation Devices and Implantable Infusion Pumps Customer Analysis
8 Neuromodulation Devices and Implantable Infusion Pumps Market Dynamics
8.1 Neuromodulation Devices and Implantable Infusion Pumps Industry Trends
8.2 Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
8.3 Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
8.4 Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) of Key Manufacturers (2021–2026)
 Table 5. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Neuromodulation Devices and Implantable Infusion Pumps, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Product Types and Applications
 Table 12. Global Key Manufacturers of Neuromodulation Devices and Implantable Infusion Pumps, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Neuromodulation Devices and Implantable Infusion Pumps Companies by Tier (Tier 1, Tier 2, Tier 3), based on Neuromodulation Devices and Implantable Infusion Pumps Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (Unit), 2021–2026
 Table 18. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021–2026)
 Table 19. Global Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (Unit), 2027–2032
 Table 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2027–2032)
 Table 21. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021–2026)
 Table 23. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2027–2032)
 Table 25. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2021–2026
 Table 27. North America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2027–2032
 Table 28. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2021–2026
 Table 32. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2027–2032
 Table 33. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (Unit), 2021–2026
 Table 37. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales by Region (Unit), 2027–2032
 Table 38. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2021–2026
 Table 42. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2027–2032
 Table 43. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2021–2026
 Table 47. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales by Country (Unit), 2027–2032
 Table 48. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Type (2021–2026)
 Table 51. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Type (2027–2032)
 Table 52. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2021–2026)
 Table 53. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Type (2027–2032)
 Table 54. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2021–2026)
 Table 57. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Type (2027–2032)
 Table 58. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Application (2021–2026)
 Table 61. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit) by Application (2027–2032)
 Table 62. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2021–2026)
 Table 63. Global Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Application (2027–2032)
 Table 64. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2021–2026)
 Table 67. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Application (2027–2032)
 Table 68. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2027–2032)
 Table 70. Medtronic Company Information
 Table 71. Medtronic Description and Business Overview
 Table 72. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. Medtronic Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 74. Medtronic Recent Developments/Updates
 Table 75. Boston Scientific Corporation Company Information
 Table 76. Boston Scientific Corporation Description and Business Overview
 Table 77. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Boston Scientific Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 79. Boston Scientific Corporation Recent Developments/Updates
 Table 80. St. Jude Medical Company Information
 Table 81. St. Jude Medical Description and Business Overview
 Table 82. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. St. Jude Medical Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 84. St. Jude Medical Recent Developments/Updates
 Table 85. Synapse Biomedical Company Information
 Table 86. Synapse Biomedical Description and Business Overview
 Table 87. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Synapse Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 89. Synapse Biomedical Recent Developments/Updates
 Table 90. Nevro Corporation Company Information
 Table 91. Nevro Corporation Description and Business Overview
 Table 92. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Nevro Corporation Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 94. Nevro Corporation Recent Developments/Updates
 Table 95. Neuropace Company Information
 Table 96. Neuropace Description and Business Overview
 Table 97. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Neuropace Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 99. Neuropace Recent Developments/Updates
 Table 100. Cyberonics Company Information
 Table 101. Cyberonics Description and Business Overview
 Table 102. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Cyberonics Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 104. Cyberonics Recent Developments/Updates
 Table 105. Autonomic Technologies Company Information
 Table 106. Autonomic Technologies Description and Business Overview
 Table 107. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Autonomic Technologies Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 109. Autonomic Technologies Recent Developments/Updates
 Table 110. Avery Biomedical Company Information
 Table 111. Avery Biomedical Description and Business Overview
 Table 112. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Avery Biomedical Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 114. Avery Biomedical Recent Developments/Updates
 Table 115. Greatbatch Medical Company Information
 Table 116. Greatbatch Medical Description and Business Overview
 Table 117. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Greatbatch Medical Neuromodulation Devices and Implantable Infusion Pumps Product
 Table 119. Greatbatch Medical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Neuromodulation Devices and Implantable Infusion Pumps Distributors List
 Table 123. Neuromodulation Devices and Implantable Infusion Pumps Customers List
 Table 124. Neuromodulation Devices and Implantable Infusion Pumps Market Trends
 Table 125. Neuromodulation Devices and Implantable Infusion Pumps Market Drivers
 Table 126. Neuromodulation Devices and Implantable Infusion Pumps Market Challenges
 Table 127. Neuromodulation Devices and Implantable Infusion Pumps Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Neuromodulation Devices and Implantable Infusion Pumps
 Figure 2. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Type: 2025 & 2032
 Figure 4. Spinal Cord Stimulation Product Picture
 Figure 5. Deep Brain Stimulation Product Picture
 Figure 6. Sacral Nerve Stimulation Product Picture
 Figure 7. Vagal Nerve Stimulation Product Picture
 Figure 8. Gastric Stimulation Product Picture
 Figure 9. Transcranial Magnetic Stimulation Product Picture
 Figure 10. Transcutaneous Electrical Stimulation Product Picture
 Figure 11. Other Product Picture
 Figure 12. Global Neuromodulation Devices and Implantable Infusion Pumps Market Value by Application (US$ Million), 2021–2032
 Figure 13. Global Neuromodulation Devices and Implantable Infusion Pumps Market Share by Application: 2025 & 2032
 Figure 14. Parkinson's Disease
 Figure 15. Epilepsy
 Figure 16. Pain
 Figure 17. Other
 Figure 18. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 19. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size (US$ Million), 2021–2032
 Figure 20. Global Neuromodulation Devices and Implantable Infusion Pumps Sales (Unit), 2021–2032
 Figure 21. Global Neuromodulation Devices and Implantable Infusion Pumps Average Price (USD/Unit), 2021–2032
 Figure 22. Neuromodulation Devices and Implantable Infusion Pumps Report Years Considered
 Figure 23. Neuromodulation Devices and Implantable Infusion Pumps Sales Share by Manufacturers in 2025
 Figure 24. Global Neuromodulation Devices and Implantable Infusion Pumps Revenue Share by Manufacturers in 2025
 Figure 25. Top 5 and Top 10 Global Neuromodulation Devices and Implantable Infusion Pumps Players: Market Share by Revenue in Neuromodulation Devices and Implantable Infusion Pumps in 2025
 Figure 26. Neuromodulation Devices and Implantable Infusion Pumps Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 27. Global Neuromodulation Devices and Implantable Infusion Pumps Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 28. North America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021–2032)
 Figure 29. North America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021–2032)
 Figure 30. U.S. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Canada Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Europe Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021–2032)
 Figure 33. Europe Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021–2032)
 Figure 34. Germany Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. France Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. U.K. Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. Italy Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Russia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Region (2021–2032)
 Figure 40. Asia Pacific Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Region (2021–2032)
 Figure 41. China Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Japan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. South Korea Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. India Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Australia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. China Taiwan Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Indonesia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Thailand Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Malaysia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Latin America Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021–2032)
 Figure 51. Latin America Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021–2032)
 Figure 52. Mexico Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Brazil Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. Argentina Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Sales Market Share by Country (2021–2032)
 Figure 56. Middle East and Africa Neuromodulation Devices and Implantable Infusion Pumps Revenue Market Share by Country (2021–2032)
 Figure 57. Turkey Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 58. Saudi Arabia Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 59. UAE Neuromodulation Devices and Implantable Infusion Pumps Revenue Growth Rate (US$ Million), 2021–2032
 Figure 60. Global Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2021–2032)
 Figure 61. Global Revenue Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Type (2021–2032)
 Figure 62. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Type (2021–2032)
 Figure 63. Global Sales Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2021–2032)
 Figure 64. Global Revenue Market Share of Neuromodulation Devices and Implantable Infusion Pumps by Application (2021–2032)
 Figure 65. Global Neuromodulation Devices and Implantable Infusion Pumps Price (USD/Unit) by Application (2021–2032)
 Figure 66. Neuromodulation Devices and Implantable Infusion Pumps Value Chain
 Figure 67. Channels of Distribution (Direct Vs Distribution)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure